Comparison of the effect of fluvastatin, an hydroxymethyl glutaryl coenzyme A reductase inhibitor, and cholestyramine, a bile acid sequestrant, on lipoprotein particles defined by apolipoprotein composition

This publication has 25 references indexed in Scilit:

• HMG CoA reductase inhibitors
  Current Opinion in Lipidology, 1994
• Parental history of early myocardial infarction is associated with decreased levels of lipoparticle AI in adolescents.
  Arteriosclerosis and Thrombosis: A Journal of Vascular Biology, 1993
• Protein composition determines the anti-atherogenic properties of HDL in transgenic mice
  Nature, 1993
• Quantitative Determination of Different Apolipoprotein B Containing Lipoproteins by an Enzyme Linked Immunosorbent Assay: Apo B with Apo C-III and Apo B with Apo E
  Journal of Immunoassay, 1991
• Isolation and characterization of human Lp-B lipoprotein containing apolipoprotein B as the sole apolipoprotein
  Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1991
• Apolipoprotein E-rich HDL in patients with homozygous familial hypercholesterolemia
  Atherosclerosis, 1990
• Lipid lowering drugs.
  BMJ, 1990
• Apolipoprotein A-I containing lipoproteins in coronary artery disease
  Atherosclerosis, 1987
• Cholesterol efflux from cultured adipose cells is mediated by LpAI particles but not by LpAI:AII particles
  Biochemical and Biophysical Research Communications, 1987
• The Lipid Research Clinics Coronary Primary Prevention Trial results. II. The relationship of reduction in incidence of coronary heart disease to cholesterol lowering
  JAMA, 1984